DSM-5 further inflates attention deficit hyperactivity disorder

Journal of Nervous and Mental Disease

Volumn 200, Issue 6, 2012, Pages 486-488

  Batstra, Laura ^a   Frances, Allen ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ADHD; diagnostic inflation; DSM

Indexed keywords

ARTICLE; ATTENTION DEFICIT DISORDER; COST; DSM-5; DSM-IV; HUMAN; IMPULSIVENESS; ONSET AGE; PREVALENCE; RISK;

ADOLESCENT; ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUSTRY; DRUG UTILIZATION; FEMALE; HUMANS; MALE; SOCIAL MARKETING; UNITED STATES;

EID: 84862221521     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/NMD.0b013e318257c4b6     Document Type: Article

References (27)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (DSM-IV). (4th ed) Washington, DC: American Psychiatric Association.
2. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
3. Ashton H, Gallagher P, Moore B (2006) The adult psychiatrist's dilemma: Psychostimulant use in attention deficit/hyperactivity disorder. J Psychopharmacol. 20:602-610. doi:10.1177/0269881106061710.
4. Bellak L, Black RB (1992) Attention-deficit hyperactivity disorder in adults. Clin Ther. 14:138-147.
5. Centers for Disease Control and Prevention (2010)Increasing prevalence of parentreported attention-deficit/hyperactivity disorder among childrenVUnited States, 2003 and 2007. MMWR. 59: 1439-1443.
6. Chilakamarri JK, Filkowski MM, Ghaemi SN (2011) Misdiagnosis of bipolar disorder in children and adolescents: A comparison with ADHD and major depressive disorder. Ann Clin Psychiatry. 23:25-29.
7. Coghill D, Seth S (2011) Do the diagnostic criteria for ADHD need to change? Comments on the preliminary proposals of the DSM-5 ADHD and Disruptive Behavior Disorders Committee. Eur Child Adolesc Psychiatry. 20:75-81.
8. Crone EA (2009) Executive functions in adolescence: Inferences from brain and behavior. Dev Sci. 12:825-830.
9. Goldman LS, Genel M, Bezman RJ, Slanetz PJ (1998) Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA. 279:1100-1107.
10. Kociancic T, Reed MD, Findling RL (2004) Evaluation of risks associated with short-and long-term psychostimulant therapy for treatment of ADHD in children. Expert Opin Drug Saf. 3:93-100. doi:10.1517/eods.3.2.93.27337.
11. Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugué M, Carpentier PJ, Edvinsson D, Fayyad J, Foeken K, Fitzgerald M, Gaillac V, Ginsberg Y, Henry C, Krause J, Lensing MB, Manor I, Niederhofer H, Nunes-Filipe C, Ohlmeier MD, Oswald P, Pallanti S, Pehlivanidis A, Ramos-Quiroga JA, Rastam M, Ryffel-Rawak D, Stes S, Asherson P (2010) European consensus statement on diagnosing adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 3:10-67.
12. Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW, Barkley RA, Newcorn J, Jensen P, Richters J, Garfinkel B, Kerdyk L, Frick PJ, Ollendick T, Perez D, Hart EL, Waldman I, Shaffer D (1994) DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry. 151:1673-1685.
13. Lang HC, Scheffler RM, Hu TW (2010) The discrepancy in attention deficit hyperactivity disorder (ADHD) medications diffusion: 1994-2003VA global pharmaceutical data analysis. Health Policy. 97:71-78.
14. McGough JJ, Smalley SL, McCracken JT, Yang M, Del'Homme M, Lynn DE, Loo S (2005) Psychiatric comorbidity in adult attention deficit hyperactivity disorder: Findings from multiplex families. Am J Psychiatry. 162:1621-1627.
15. Montejano L, Sasané R, Hodgkins P, Russo L, Huse D (2011) Adult ADHD: Prevalence of diagnosis in a US population with employer health insurance. Curr Med Res Opin. 27:5-11.
16. Ohan JL, Visser TA, Strain MC, Allen L (2011) Teachers' and education students' perceptions of and reactions to children with and without the diagnostic label "ADHD". J Sch Psychol. 49:81-105.
17. Olfson M, Marcus SC, Weissman MM, Jensen PS (2002) National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry. 41:514-521.
18. Polanczyk G, Caspi A, Houts R, Kollins SH, Rohde LA, Moffitt TE (2010) Implications of extending the ADHD age-of-onset criterion to age 12: Results from a prospectively studied birth cohort. J Am Acad Child Adolesc Psychiatry. 49:210-216.
19. Porter DM (2011) Direct-to-consumer (DTC) pharmaceutical marketing: Impacts and policy implications. SPNHA Rev 7(1), Article 5. Retrieved from http://scholarworks.gvsu.edu/spnhareview/vol7/iss1/5. Accessed on December 15, 2011.
20. Robbins TW, Gillan CM, Smith DG, de Wit S, Ersche KD (2012) Neurocognitive endophenotypes of impulsivity and compulsivity: Towards dimensional psychiatry. Trends Cogn Sci. 16:81-91.
21. Robison LM, Sclar DA, Skaer TL (2005) Trends in ADHD and stimulant use among adults: 1995-2002. Psychiatr Serv. 56:1497.
22. Sciutto MJ, Eisenberg M (2007) Evaluating the evidence for and against overdiagnosis of ADHD. J Atten Disord. 11:106-113.
23. Staller J, Faraone SV (2006) Attention-deficit hyperactivity disorder in girls: Epidemiology and management. CNS Drugs. 20:107-123
24. Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH (2003) A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 112:e404.
25. Swann AC (2011) Antisocial personality and bipolar disorder: Interactions in impulsivity and course of illness. Neuropsychiatry. 1:599-610.
26. Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S (2008) Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 47: 21-31.
27. Zima BT, Bussing R, Lingqu T, Tang L, Zhang L, Ettner S, Belin TR, Wells KB (2010) Quality of care for childhood attention deficit/hyperactivity disorder in a managed care Medicaid program. J Am Acad Child Adolesc Psychiatry. 49: 1225-1237.